Author:
Veach Darren R.,Namavari Mohammad,Beresten Tatiana,Balatoni Julius,Minchenko Maria,Djaballah Hakim,Finn Ronald D.,Clarkson Bayard,Gelovani Juri G.,Bornmann William G.,Larson Steven M.
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine
Reference45 articles.
1. The pyrido[2,3-d]pyrimidine derivative PD180970 inhibits p210Bcr–Abl tyrosine kinase and induces apoptosis of K562 leukemic cells;Dorsey;Cancer Res,2000
2. Characterization of potent inhibitors of the Bcr–Abl and the c-kit receptor tyrosine kinases;Wisniewski;Cancer Res,2002
3. Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors;Kraker;Biochem Pharmacol,2000
4. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999
5. The development of imatinib as a therapeutic agent for chronic myeloid leukemia;Deininger;Blood,2004
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献